Ethyl trifluoroacetate | CAS:383-63-1

We serve Ethyl trifluoroacetate CAS:383-63-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Ethyl trifluoroacetate

Chemical Name:Ethyl trifluoroacetate
CAS.NO:383-63-1
Synonyms:Ethyl trifluoroacetate
ethyl 2,2,2-trifluoroacetate
Trifluoroacetic Acid Ethyl Ester
Acetic acid, trifluoro-, ethyl ester
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 61.5±3.0 °C at 760 mmHg
Melting Point -78 °C
Molecular Formula C4H5F3O2
Molecular Weight 142.077
Flash Point -1.1±0.0 °C
 
Specification:
Appearance:Colorless tranparent liquid
Assay(GC):≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Celecoxib(CAS:169590-42-5).



Contact us for information like Ethyl trifluoroacetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Acetic acid, trifluoro-, ethyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Trifluoroacetic Acid Ethyl Ester Use and application,Ethyl trifluoroacetate technical grade,usp/ep/jp grade.


Related News: The insulin-only and bihormonal configurations may be helpful in diabetes.2-Trifluoromethoxyphenol manufacturer “Traditional medicine is a treasure of Chinese civilization embodying the wisdom of the nation and its people,” Xi said at the meeting in Beijing.4,6-dibromodibenzothiophene supplier “Traditional medicine is a treasure of Chinese civilization embodying the wisdom of the nation and its people,” Xi said at the meeting in Beijing.(2S,3S)-1,2-Epoxy-3-(Cbz-amino)-4-phenylbutane vendor “Traditional medicine is a treasure of Chinese civilization embodying the wisdom of the nation and its people,” Xi said at the meeting in Beijing.The company’s proprietary induced pluripotent stem cell (iPSC) product platform enables mass production of off-the-shelf, engineered, homogeneous cell products that can be administered with multiple doses to deliver more effective pharmacologic activity, including in combination with cycles of other cancer treatments.